Form 4: TENAX Interim CFO Buys $58K in Company Stock

TENAX Therapeutics' Interim CFO, Thomas McGauley, acquired 8,000 shares of common stock across direct and indirect holdings on November 17, 2025.

Summary

• Thomas McGauley, Interim CFO of TENAX THERAPEUTICS, INC. (TENX), reported the acquisition of common stock.
• On November 17, 2025, McGauley directly acquired 2,000 shares of common stock at a weighted average price of $7.337 per share.
• These direct shares were purchased in multiple trades ranging from $7.14 to $7.43.
• Additionally, 1,000 shares were indirectly acquired by a child at a price of $7.35 per share on the same date.
• An additional 5,000 shares were indirectly acquired by a spouse at a weighted average price of $7.228 per share on November 17, 2025.
• These indirect shares by spouse were purchased in multiple trades ranging from $7.17 to $7.30.
• Following these transactions, McGauley beneficially owns a total of 8,000 shares of common stock (2,000 directly, 1,000 indirectly by child, and 5,000 indirectly by spouse).

Sentiment

Score: 7

Explanation: The insider purchase by a key executive is a positive indicator of management confidence, though the transaction size is moderate and no other financial or strategic details are provided in this filing.

Positives

• The Interim CFO's purchase of company stock signals confidence in the company's future prospects.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.

Industry Context

Insider buying, particularly by a key executive like the Interim CFO, is often interpreted by the market as a positive signal, suggesting that management believes the company's stock is undervalued or expects positive developments. This can sometimes lead to increased investor confidence in the company compared to its peers.

Corporate Governance

Related Party Transactions

• Indirect acquisition of 1,000 shares by a child of the reporting person.
• Indirect acquisition of 5,000 shares by a spouse of the reporting person.

Stakeholder Impact

• Shareholders may view the insider buying as a positive sign of management's belief in the company's value, potentially boosting investor confidence.

Key Dates

Recommendation

The Interim CFO's purchase of company stock indicates management confidence, which is generally a positive signal for investors. However, without broader financial context or strategic updates, a 'hold' recommendation is prudent, awaiting further company developments.

Keywords

TENAX Therapeutics, TENX, insider trading, Form 4, stock purchase, CFO, Thomas McGauley, Rule 10b5-1